Hamid Riazi-Esfahani Selected Research

Hamid Riazi-Esfahani Research Topics

Disease

9	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2024 - 07/2019
7	Macular Edema 10/2022 - 04/2018
6	Retinal Detachment (Retinal Detachments) 02/2023 - 01/2020
6	Retinopathy of Prematurity (Retrolental Fibroplasia) 07/2022 - 01/2018
5	Macular Degeneration (Age-Related Maculopathy) 02/2024 - 10/2014
5	Retinal Vein Occlusion 02/2024 - 07/2019
4	COVID-19 02/2024 - 05/2021
4	Retinoblastoma (Glioblastoma, Retinal) 04/2023 - 01/2021
4	Cataract (Cataracts) 01/2023 - 04/2018
3	Atrophy 03/2023 - 01/2021
2	Cysts 01/2024 - 03/2020
2	Central Serous Chorioretinopathy 09/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 07/2023 - 01/2020
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2023 - 10/2014
2	Endophthalmitis (Ophthalmia) 11/2022 - 01/2021
2	Retinal Perforations 10/2022 - 07/2015
2	Lymphoma (Lymphomas) 04/2022 - 02/2022
2	Melanoma (Melanoma, Malignant) 11/2021 - 01/2020
2	Choroidal Neovascularization 01/2021 - 01/2020
2	Neoplasms (Cancer) 01/2021 - 01/2021
1	Fibrosis (Cirrhosis) 03/2024
1	High Hyperopia 03/2024
1	Hamartoma 12/2023
1	Tuberous Sclerosis (Bourneville's Disease) 12/2023
1	Uveal melanoma 08/2023
1	Chronic Renal Insufficiency 04/2023
1	Acute Kidney Injury (Acute Renal Failure) 04/2023
1	photopsia 03/2023
1	Low Vision (Subnormal Vision) 03/2023
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2023
1	Heart Failure 01/2023
1	Inflammation (Inflammations) 01/2023
1	Edema (Dropsy) 10/2022
1	Proliferative Vitreoretinopathy 02/2022
1	Retinitis 01/2022
1	Necrosis 01/2022
1	Uveitis 01/2022
1	Ischemia 10/2021
1	Vision Disorders (Hemeralopia) 09/2021
1	Infections 05/2021
1	Retinal Dystrophies 05/2021
1	Vascular Diseases (Vascular Disease) 02/2021
1	Optic Atrophy 01/2021
1	Vitreous Hemorrhage 01/2021
1	Glaucoma 01/2021
1	Corneal Injuries 01/2021
1	Hyphema 01/2021
1	Disease Progression 01/2021
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Sickle Cell Trait 01/2021
1	Ocular Toxoplasmosis 01/2021

Drug/Important Bio-Agent (IBA)

27	Retinaldehyde (Retinal)IBA 03/2024 - 10/2014
8	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2018
4	afliberceptIBA 02/2024 - 01/2020
4	Silicone OilsIBA 02/2022 - 12/2020
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2020
2	Tamoxifen FDA LinkGeneric 07/2023 - 01/2020
2	Melphalan (Alkeran)FDA LinkGeneric 04/2023 - 01/2021
2	Fluorescein (Funduscein)FDA LinkGeneric 04/2023 - 01/2022
2	Carboplatin (JM8)FDA LinkGeneric 04/2023 - 01/2021
1	Biosimilar PharmaceuticalsIBA 02/2024
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 02/2024
1	Selective Estrogen Receptor Modulators (SERM)IBA 07/2023
1	Coloring Agents (Dyes)IBA 04/2023
1	CreatinineIBA 04/2023
1	Niclosamide FDA Link 03/2023
1	ElementsIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023
1	InterferonsIBA 10/2022
1	Methotrexate (Mexate)FDA LinkGeneric 04/2022
1	Rituximab (Mabthera)FDA Link 04/2022
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2022
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2022
1	Ruthenium-106IBA 11/2021
1	RutheniumIBA 11/2021
1	dorzolamide (Trusopt)FDA LinkGeneric 05/2021
1	Carbonic Anhydrase InhibitorsIBA 05/2021
1	Retinal Pigments (Pigments, Visual)IBA 01/2021
1	closantelIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	TabletsIBA 01/2021

Therapy/Procedure

8	Vitrectomy 02/2023 - 07/2015
5	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
5	Intravitreal Injections 11/2022 - 07/2019
5	Light Coagulation 02/2022 - 01/2018
4	Injections 11/2022 - 01/2021
3	Brachytherapy 08/2023 - 01/2020
2	Phacoemulsification 02/2023 - 06/2018
2	Therapeutics 01/2023 - 06/2019
2	Radiotherapy 04/2022 - 11/2021
2	Aftercare (After-Treatment) 11/2021 - 04/2018
2	Scleral Buckling 09/2020 - 01/2020
1	Slit Lamp 01/2024
1	Photochemotherapy (Photodynamic Therapy) 09/2023
1	Immunotherapy 04/2022
1	Orthoptics (Orthoptic) 09/2021
1	Immunomodulation 05/2021